Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
Introduction Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-associated mortality globally. Immune-checkpoint blockade (ICB) is one of the systemic therapy options for HCC. However, response rates remain low, necessitating robust predictive biomarkers. In the present study, we e...
        Saved in:
      
    
          | Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | BMJ Publishing Group
    
        2020-10-01 | 
| Series: | Journal for ImmunoTherapy of Cancer | 
| Online Access: | https://jitc.bmj.com/content/8/2/e000987.full | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
 
       